10/15/2021 3:42:30 PM EDT
Buena, New Jersey, USA
Oct 14, 2021
Teligent Inc. (TLGT) shares are falling on Thursday morning trade after the company announced the filing for asset sale through voluntary chapter 11 process. The company said it will arrange $12 million debtor-in-possession financing from senior secured lenders.
The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts
Teligent Inc. (TLGT), a New Jersey-based specialty generic pharmaceutical company, said that it filed for voluntary protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware to pursue a sale process that is intended to maximize the value of the company.
Teligent Files For Voluntary Chapter 11 Bankruptcy
Teligent To Pursue Asset Sale Through Voluntary Chapter 11 Process
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market.
ChartExchange on Twitter
© 2020 - 2021 ChartExchange LLC